Zydus Lifesciences to Buy Amplitude Surgical for €257 Million
Mar 11, 2025


Source: The Hindu
Share:
Zydus Lifesciences Ltd. has signed exclusive talks to buy a majority stake in France's Amplitude Surgical for €256.8 million. The deal makes Zydus stronger in the global medical technology industry and broadens its healthcare solutions from pharmaceuticals to orthopedic surgical technologies.
Key Highlights
Acquisition Details:
Zydus Lifesciences will buy Amplitude Surgical, a prominent European MedTech firm with expertise in lower-limb orthopedic technologies.
The purchase price is an 80.6% premium on Amplitude's recent closing price and more than 90% premium on its 3-month and 6-month volume-weighted average price.
The transaction is consistent with Zydus' long-term growth strategy, strengthening global market reach and technological prowess.
About Amplitude Surgical:
Amplitude Surgical is a high-quality orthopedic technology European leader specializing in lower-limb surgery.
The firm is renowned for value-added innovations that advance patient outcomes, improve surgical efficiency, and facilitate healthcare facilities.
Amplitude Surgical enjoys a solid market foothold in Europe with future expansion planned across the world.
Strategic Significance to Zydus:
Represents Zydus' foray into the MedTech industry, diversifying its healthcare portfolio from pharmaceuticals.
Builds on Amplitude's strength to bolster Zydus' leadership position in the orthopedic and surgical technology segment.
Strengthens manufacturing capacity and extends geographical reach in key markets.
Quotes from Zydus Management
Sharvil Patel, Managing Director, Zydus Lifesciences Ltd., stated:
"We think it was a logical extension into the medical technology space. We can see a few growth opportunities here in terms of portfolio expansion, manufacturing capabilities, and geography. This acquisition makes Zydus a more competitive player in the global healthcare system."Zydus Lifesciences' acquisition of Amplitude Surgical represents a strategic foray into the MedTech space, reaffirming its focus on innovation in orthopedic solutions. The acquisition will allow Zydus to expand its product portfolio, enhance its global presence, and leverage opportunities in surgical healthcare technologies growth.
Copyright © 2024 Pharmacy Pro. All rights reserved
Copyright © 2024 Pharmacy Pro. All rights reserved
Copyright © 2024 Pharmacy Pro. All rights reserved


Source: The Hindu
Zydus Lifesciences Ltd. has signed exclusive talks to buy a majority stake in France's Amplitude Surgical for €256.8 million. The deal makes Zydus stronger in the global medical technology industry and broadens its healthcare solutions from pharmaceuticals to orthopedic surgical technologies.
Key Highlights
Acquisition Details:
Zydus Lifesciences will buy Amplitude Surgical, a prominent European MedTech firm with expertise in lower-limb orthopedic technologies.
The purchase price is an 80.6% premium on Amplitude's recent closing price and more than 90% premium on its 3-month and 6-month volume-weighted average price.
The transaction is consistent with Zydus' long-term growth strategy, strengthening global market reach and technological prowess.
About Amplitude Surgical:
Amplitude Surgical is a high-quality orthopedic technology European leader specializing in lower-limb surgery.
The firm is renowned for value-added innovations that advance patient outcomes, improve surgical efficiency, and facilitate healthcare facilities.
Amplitude Surgical enjoys a solid market foothold in Europe with future expansion planned across the world.
Strategic Significance to Zydus:
Represents Zydus' foray into the MedTech industry, diversifying its healthcare portfolio from pharmaceuticals.
Builds on Amplitude's strength to bolster Zydus' leadership position in the orthopedic and surgical technology segment.
Strengthens manufacturing capacity and extends geographical reach in key markets.
Quotes from Zydus Management
Sharvil Patel, Managing Director, Zydus Lifesciences Ltd., stated:
"We think it was a logical extension into the medical technology space. We can see a few growth opportunities here in terms of portfolio expansion, manufacturing capabilities, and geography. This acquisition makes Zydus a more competitive player in the global healthcare system."Zydus Lifesciences' acquisition of Amplitude Surgical represents a strategic foray into the MedTech space, reaffirming its focus on innovation in orthopedic solutions. The acquisition will allow Zydus to expand its product portfolio, enhance its global presence, and leverage opportunities in surgical healthcare technologies growth.
Share:
Read Next
Read Next
Copyright © 2024 Pharmacy Pro. All rights reserved
Copyright © 2024 Pharmacy Pro. All rights reserved